| Bioactivity | Regorafenib-d3 is a deuterium labeled Regorafenib. Regorafenib is a multi-targeted receptor tyrosine kinase inhibitor[1]. | |||||||||
| Name | Regorafenib-d3 | |||||||||
| CAS | 1255386-16-3 | |||||||||
| Formula | C21H12D3ClF4N4O3 | |||||||||
| Molar Mass | 485.83 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Wilhelm SM, et al. Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity. Int J Cancer, 2011, 129(1), 245-255. |
Regorafenib-d3
CAS: 1255386-16-3 F: C21H12D3ClF4N4O3 W: 485.83
Regorafenib-d3 is a deuterium labeled Regorafenib. Regorafenib is a multi-targeted receptor tyrosine kinase inhibitor.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.